Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble.
Flexion Therapeutics Inc (NASDAQ: FLXN)
Popular Searches
Operator
Good afternoon, ladies and gentlemen, and welcome to the Flexion Therapeutics Business Update Call. [Operator Instructions]
I will now turn the call over to Scott Young, Flexion s Vice President of Corporate Communications and Investor Relations.SPONSORED:
10 stocks we like better than Flexion Therapeutics
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,
Motley Fool Stock Advisor, has tripled the market.
Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Flexion Therapeutics Inc (FLXN) Q4 2020 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Share:
Shares of Yumanity to commence trading on Nasdaq under new ticker symbol YMTX on December 23, 2020
$33.6 million common stock private investment in public equity ( PIPE ) transaction closes concurrently with the merger
BOSTON, Dec. 23, 2020 (GLOBE NEWSWIRE) Yumanity Therapeutics (NASDAQ:YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced that its reverse merger with Proteostasis Therapeutics, Inc. closed on December 22, 2020, following the approval of Proteostasis shareholders. The combined company will operate under the name Yumanity Therapeutics, Inc., and its shares will commence trading on the Nasdaq Capital Market on December 23, 2020, under the ticker symbol YMTX. The $33.6 million PIPE transaction, announced on December 15, closed concurrently with the merger.